MARC details
000 -LEADER |
fixed length control field |
04543nam a22005415i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20231109085910.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220211s2022 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783030899189 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-3-030-89918-9 |
Source of number or code |
doi |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
TR-AnTOB |
Language of cataloging |
eng |
Transcribing agency |
TR-AnTOB |
Description conventions |
rda |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QZ 266 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJ |
Source |
bicssc |
|
Subject category code |
MED062000 |
Source |
bisacsh |
|
Subject category code |
MJ |
Source |
thema |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
QZ266EBK |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Cyr, Claude. |
Relator term |
author. |
Relator code |
aut |
-- |
http://id.loc.gov/vocabulary/relators/aut |
245 10 - TITLE STATEMENT |
Title |
Cannabis and Cannabinoid-Based Medicines in Cancer Care |
Medium |
[electronic resource] : |
Remainder of title |
A Comprehensive Guide to Medical Management / |
Statement of responsibility, etc. |
by Claude Cyr, Mellar P. Davis, Danial Schecter, Paul Daeninck. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. 2022. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cham : |
Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Overview of the Endocannabinoid System and Endocannabinoidome -- Cannabinoid-Based Medicine: Pharmacology and Drug Interactions -- Future Therapeutic Potential of Synthetic Cannabinoids and Endocannabinoid System Modulators -- Cannabis-Based Medicines as Anti-Cancer Agents -- Cannabinoid-Based Medicines and Cancer Symptom Management -- Patient Evaluation: Precautions and Managing Expectations -- Choosing a Product, Route of Administration, Initial Dosage, Titration, Monitoring and Management of Adverse Effects -- Psychoactive Effects of Cannabinoid-Based Medicines: Exploration and Inquiry. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
The use of cannabinoid-based medicines (CBM), and cannabis in particular, has risen steadily among cancer and palliative care patients over the last few years. This textbook aims to address the multiple challenges facing healthcare providers regarding the use of CBM in this vulnerable patient population. It provides insight into the latest preclinical and clinical data and offers a practical approach on the use of CBM in a rapidly evolving landscape. It answers questions regarding the prescribing process and elucidates controversies regarding cannabis’ disease-modifying effects. The first chapters will review basic concepts of the endocannabinoid system and pharmacology of CBM, while focusing more specifically on the unique characteristics of two main cannabinoids: THC and CBD. Indicating which benefits can be expected from using either or both of these compounds, the book then addresses issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patients with polypharmacy and multiple comorbidities. Comparing available products, both approved and non-approved by the FDA, the book discusses regional challenges for accessing reliably tested and labelled products in the context of standardization efforts. After carefully determining objectives and addressing patient expectations, further chapters will examine the different clinical settings in which CBM may be useful in cancer care and explore symptom management, including cancer pain, anxiety, nausea, and insomnia among others. The possible benefits of cannabis psychoactivity will also be discussed, including harm reduction strategies for patients who wish to explore these effects. Cannabis and Cannabinoid-Based Medicines in Cancer Care: A Comprehensive Guide to Medical Management serves as a comprehensive text for oncologists, palliative care specialists, general practitioners, and nurse practitioners working with cancer patients or in palliative care settings. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Internal medicine. |
|
Topical term or geographic name entry element |
Pain medicine. |
|
Topical term or geographic name entry element |
Palliative treatment. |
|
Topical term or geographic name entry element |
Internal Medicine. |
|
Topical term or geographic name entry element |
Pain Medicine. |
|
Topical term or geographic name entry element |
Palliative Care. |
653 #0 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Cannabinoids |
|
Uncontrolled term |
Cancer -- treatment |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Davis, Mellar P. |
Relator term |
author. |
Relator code |
aut |
-- |
http://id.loc.gov/vocabulary/relators/aut |
|
Personal name |
Schecter, Danial. |
Relator term |
author. |
Relator code |
aut |
-- |
http://id.loc.gov/vocabulary/relators/aut |
|
Personal name |
Daeninck, Paul. |
Relator term |
author. |
Relator code |
aut |
-- |
http://id.loc.gov/vocabulary/relators/aut |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-030-89918-9">https://doi.org/10.1007/978-3-030-89918-9</a> |
Materials specified |
Springer eBooks |
Public note |
Online access link to the resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
E-Book |